Business ❯Corporate Strategy ❯Mergers and Acquisitions ❯Market Positioning

Investor Relations

FDA Advisers Recommend Against Approval of GSK’s Myeloma Drug Blenrep

They highlighted serious eye-related side effects in late-stage trials under review by regulators.

Discord Names Humam Sakhnini as CEO, Signaling IPO Preparations